Neuroprotective Peptide
Ara-290
Erythropoietin-based neuroprotective peptide
Starting at $285
Ara-290 is a synthetic 11-amino acid peptide derived from erythropoietin (EPO) that retains EPO's tissue-protective and anti-inflammatory properties without its erythropoietic (red blood cell stimulating) effects. It has strong neuroprotective, anti-inflammatory, and metabolic benefits.

Non-hematopoietic EPO-receptor signaling.
Tissue Protection
Innate Repair Receptor
Activates the innate repair receptor (IRR) — the EPO receptor complex expressed on non-hematopoietic tissues. This receptor mediates EPO's tissue-protective effects independent of red blood cell production.
Result: Tissue protection and repair without hematological effects
Cytokine Modulation
Anti-Inflammatory
Reduces pro-inflammatory cytokines (IL-1β, TNF-α) while promoting anti-inflammatory signals — useful in neuropathic pain, metabolic syndrome, and chronic inflammatory conditions.
Result: Systemic anti-inflammatory effects across multiple tissue types
Insulin Sensitivity
Metabolic Improvement
Improves insulin sensitivity and beta-cell function — with clinical trials showing significant improvements in glycemic control in Type 2 diabetics and prediabetics.
Result: Improved glucose metabolism and insulin sensitivity
Clinical Benefits
What you can expect from Ara-290 therapy
Neuropathic pain relief
Clinical trials show significant reduction in painful peripheral neuropathy — one of few treatments with strong evidence.
Metabolic improvement
Improves insulin sensitivity and beta-cell function in diabetes and metabolic syndrome.
Anti-inflammatory
Systemic reduction of pro-inflammatory cytokines without immunosuppression.
No red blood cell effects
Unlike EPO itself, Ara-290 doesn't affect hematocrit — safe for patients who can't use erythropoietic agents.
Tissue repair
Promotes healing and protection in heart, kidney, neural, and other vulnerable tissues.
The Process
What to expect & when
Realistic timeline for Ara-290 results
Weeks 1–4
Anti-Inflammatory Effect
Cytokine reduction begins. Neuropathic pain may start improving within the first weeks.
Months 1–3
Metabolic & Neurological Benefits
Insulin sensitivity improves. Neuropathic symptoms continue reducing.
Common questions
Everything you need to know about Ara-290 therapy
Transparent Pricing
Consultation Fees
Physician-guided care with complete pricing clarity.
Generic Consultation
Includes Any & All Services
First Visit
$400
Follow-Up
$150
- Complete health assessment
- All service areas covered
- Personalized treatment plan
- Prescription if appropriate
Specialized Consultation
Skin, Hair, Wellness, Labs, Galleri
First Visit
$300
Follow-Up
$150
- Focused specialty review
- Lab analysis included
- Targeted treatment approach
- Follow-up protocol
Peptide Consultation
Weight loss & metabolic therapies
First Visit
$50
Follow-Up
$30
- Metabolic assessment
- GLP-1 or peptide evaluation
- Dosing strategy
- Prescription included